Cushing’s Syndrome – A Complete Patient Guide

Overview

Cushing’s syndrome is a hormonal disorder caused by prolonged exposure of the body’s tissues to high levels of the hormone cortisol. Cortisol, often called the “stress hormone,” is essential for regulating metabolism, blood pressure, immune response, and the body’s reaction to stress. When cortisol is chronically elevated, it leads to a characteristic set of physical changes, metabolic disturbances, and psychological effects.

Who it affects: Cushing’s syndrome can occur at any age, but it is most commonly diagnosed in adults between 30 and 50 years old. Women are affected about three times more often than men (≈75 % of cases). Although rare in children, a pediatric form exists, usually linked to adrenal tumors.

Prevalence: The condition is uncommon, with an estimated incidence of 10–15 new cases per million people per year in the United States and Europe. Approximately 0.01 % of the general population will develop Cushing’s syndrome at some point in their lives.¹

Symptoms

Symptoms develop gradually and may be subtle at first. The classic “Cushingoid” appearance includes a combination of the following signs and symptoms:

• Weight gain and central obesity – especially around the abdomen and upper back (often described as a “buffalo hump”).
• Facial rounding (moon face) – a puffy, rounded appearance of the face.
• Skin changes
  • Thin, fragile skin that bruises easily.
  • Purple or pink stretch marks (striae) on the abdomen, thighs, breasts, or arms.
  • Acne and hirsutism (excess hair growth) in women.
• Muscle weakness – particularly proximal muscles (shoulders, hips), making it hard to climb stairs or lift objects.
• Bone loss (osteoporosis) – leading to fractures, especially in the spine.
• High blood pressure (hypertension).
• Glucose intolerance or diabetes mellitus.
• Fatigue and decreased stamina.
• Mood changes – irritability, anxiety, depression, or cognitive difficulties (“brain fog”).
• Menstrual irregularities – oligomenorrhea or amenorrhea in women; decreased libido and erectile dysfunction in men.
• Impaired wound healing and increased susceptibility to infections.

Causes and Risk Factors

Primary (endogenous) Cushing’s syndrome

Caused by the body producing excess cortisol on its own:

• Pituitary adenoma (Cushing’s disease) – a benign tumor in the pituitary gland that secretes excess adrenocorticotropic hormone (ACTH), stimulating the adrenal glands. Accounts for ~70 % of endogenous cases.
• Ectopic ACTH secretion – tumors outside the pituitary (e.g., small‑cell lung cancer, carcinoid tumors) produce ACTH.
• Adrenal tumors – benign adenomas or malignant carcinomas that directly secrete cortisol.

Secondary (exogenous) Cushing’s syndrome

Results from long‑term use of glucocorticoid medications (e.g., prednisone, dexamethasone) prescribed for conditions such as asthma, rheumatoid arthritis, lupus, or organ transplantation.

Risk factors

• Prolonged use (>3 months) of high‑dose glucocorticoids.
• History of pituitary or adrenal tumors.
• Smoking (increases risk of ectopic ACTH‑producing lung tumors).
• Family history of endocrine tumors (e.g., multiple endocrine neoplasia type 1).

Diagnosis

Because symptoms overlap with common conditions (obesity, metabolic syndrome), diagnosis requires biochemical confirmation and imaging.

Screening tests

1. 24‑hour urinary free cortisol (UFC) – measures cortisol excreted in urine. Elevated levels on at least two separate collections suggest Cushing’s.
2. Late‑night salivary cortisol – cortisol should be low at night; a high midnight value is abnormal.
3. Low‑dose dexamethasone suppression test (LDDST) – 1 mg dexamethasone taken at night; cortisol should suppress <8 µg/dL the next morning. Lack of suppression indicates excess cortisol.

Confirmatory & localization tests

• High‑dose dexamethasone suppression test – distinguishes pituitary from ectopic ACTH sources.
• Plasma ACTH level – low ACTH suggests adrenal cause; high ACTH points toward pituitary or ectopic source.
• Imaging
  • MRI of the pituitary (first‑line for suspected Cushing’s disease).
  • CT scan of adrenal glands if ACTH is low.
  • Chest and abdomen CT or PET scans for ectopic ACTH tumors.

All testing should be interpreted by an endocrinologist experienced in Cushing’s syndrome.

Treatment Options

General principles

• Identify and remove the underlying source of excess cortisol whenever possible.
• Control cortisol levels pre‑operatively to reduce surgical risk.
• Provide lifelong monitoring for recurrence.

Surgical interventions

• Pituitary adenoma – transsphenoidal surgery is the gold standard, achieving remission in ~70–80 % of microadenomas.
• Adrenal tumor – laparoscopic adrenalectomy (partial or total) offers cure rates >90 % for benign lesions.
• Ectopic ACTH tumor – surgical excision when the primary tumor is localized.

Radiation therapy

Used when surgery is incomplete or not feasible, especially for pituitary adenomas. Stereotactic radiosurgery (Gamma Knife) can achieve remission over 2–5 years in 50–60 % of cases.

Medications

Pharmacologic therapy aims to block cortisol synthesis or its action:

• Ketoconazole – inhibits adrenal steroidogenesis; effective in ~70 % of patients.
• Metyrapone – blocks 11β‑hydroxylase; useful for pre‑operative control.
• Osilodrostat (LUNESTA) – newer inhibitor of 11β‑hydroxylase; FDA‑approved for Cushing’s disease.
• Mifepristone – glucocorticoid receptor antagonist, indicated for hyperglycemia secondary to Cushing’s.
• Etomidate – IV infusion used in severe, life‑threatening hypercortisolism (ICU setting).

Management of glucocorticoid‑induced (exogenous) Cushing’s

Gradual tapering of the offending medication under physician supervision is essential to avoid adrenal insufficiency.

Lifestyle & supportive measures

• Low‑sodium, heart‑healthy diet to control blood pressure.
• Regular weight‑bearing exercise to preserve bone density.
• Blood glucose monitoring and, if needed, antidiabetic medications.
• Calcium (1,200 mg) and vitamin D (800–1,000 IU) supplementation.

Living with Cushing’s Syndrome

Even after treatment, many patients continue to experience residual effects. A proactive approach improves quality of life.

Daily management tips

• Medication adherence – keep a medication list; set reminders for doses.
• Regular follow‑up – endocrinology appointments every 3–6 months for the first two years, then annually.
• Bone health – Dual‑energy X‑ray absorptiometry (DEXA) scan at diagnosis and every 1–2 years; consider bisphosphonates if osteoporosis progresses.
• Blood pressure & glucose – Home monitoring; keep a log for your physician.
• Psychological support – Counseling or support groups (e.g., Cushing’s Support Group) help address mood changes.
• Skin care – Gentle cleansing, moisturizers, and protection from bruising.
• Vaccinations – Flu and pneumococcal vaccines are recommended because cortisol suppresses immunity.

Returning to work & activity

Most patients can resume normal activities once cortisol levels are controlled. Discuss workplace accommodations if fatigue or mood swings persist.

Prevention

Primary prevention focuses on the modifiable cause—exogenous glucocorticoid exposure.

• Use the lowest effective dose for the shortest duration possible.
• Ask your prescriber about alternative therapies (e.g., non‑steroidal anti‑inflammatory drugs, inhaled steroids with spacer devices).
• Never abruptly stop long‑term steroids; taper under medical supervision.
• Maintain a healthy weight, regular exercise, and a balanced diet to lower the risk of developing obesity‑related cortisol excess.
• Screen for adrenal or pituitary tumors in patients with unexplained hypertension, diabetes, or fracture history.

Complications

If untreated, chronically high cortisol can damage multiple organ systems:

• Cardiovascular disease – accelerated atherosclerosis, myocardial infarction, stroke.
• Diabetes mellitus – up to 50 % of patients develop impaired glucose tolerance.
• Osteoporosis & fractures – especially vertebral compression fractures.
• Infections – due to immune suppression, including pneumonia and skin infections.
• Psychiatric disorders – major depressive disorder, anxiety, psychosis.
• Pregnancy complications – increased risk of gestational diabetes, hypertension, and pre‑term birth.
• Mortality – untreated Cushing’s syndrome has a 5‑year mortality rate of 30‑50 %, largely from cardiovascular causes.²

When to Seek Emergency Care

References

1. Mayo Clinic. “Cushing syndrome.” Updated 2023. https://www.mayoclinic.org.
2. Feelders RA, et al. “Long-term outcome and mortality in Cushing’s syndrome.” *The Lancet Diabetes & Endocrinology*, 2021;9(8):539‑549. DOI:10.1016/S2213-8587(21)00123-4.
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Cushing’s Syndrome.” 2022. https://www.niddk.nih.gov.
4. American College of Endocrinology. “Clinical practice guidelines for the diagnosis and treatment of Cushing’s disease.” 2024.
5. World Health Organization. “Guidelines for the management of glucocorticoid‑induced hypercortisolism.” 2023.